The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 02, 2018

Filed:

Oct. 16, 2015
Applicant:

Nippon Kayaku Kabushiki Kaisha, Tokyo, JP;

Inventors:

Shinya Fujita, Tokyo, JP;

Shin Aoki, Tokyo, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C07D 491/00 (2006.01); A61K 31/44 (2006.01); A61K 38/00 (2006.01); A61K 47/48 (2006.01); A61K 9/08 (2006.01); A61K 9/19 (2006.01); A61K 31/4745 (2006.01); C08G 81/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/48207 (2013.01); A61K 9/08 (2013.01); A61K 9/19 (2013.01); A61K 31/4745 (2013.01); C08G 81/00 (2013.01);
Abstract

Provided is a pharmaceutical preparation composition comprising a polymerized camptothecin derivative which is obtained by bonding a camptothecin derivative to a polymer carrier, and has nanoparticle-forming properties of associating in an aqueous solution, the pharmaceutical preparation composition having enhanced preparation stability. Particularly, a pharmaceutical preparation maintaining nanoparticle-forming properties, which are an important factor, and having an excellent storage stability is provided. Disclosed is a pharmaceutical preparation comprising a block copolymer in which a polyethylene glycol segment is linked to a polyglutamic acid segment containing a glutamic acid unit having a camptothecin derivative bonded thereto, the pharmaceutical preparation capable of forming associates in an aqueous solution. When the pharmaceutical preparation is made into an aqueous solution containing the camptothecin derivative at a concentration of 1 mg/mL, the pH of the aqueous solution is 2.4 to 7.0, and the change ratio of the associate-forming ability of the pharmaceutical preparation after storage at 40° C. for one week under light-blocked conditions is 50% or less.


Find Patent Forward Citations

Loading…